Startup to develop antidote to cyanide poisoning
from R&D Magazine
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063